Find your next paid study

National Institute of Mental Health (NIMH)NCT00271622

~$10 – $675

Irritability Associated With Autism Spectrum Disorder

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder

The purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.

Bristol-Myers SquibbNCT07285798

~$10 – $7,500

SchizophreniaBipolar DisorderAutism Spectrum Disorder

An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone in the Treatment of Pediatric Patients With Schizophrenia, Bipolar Disorder, or Autism Spectrum Disorder

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipola…

Intra-Cellular Therapies, Inc.NCT06229210

An Observational Study of the Developing Brain, Impulsivity and Compulsivity

Background: Impulsivity is acting 'without thinking.' Compulsivity is being overly inflexible. People vary in how impulsive or compulsive they are. Extreme ve…

Typical DevelopmentObsessive Compulsive DisorderConduct Disorder+2 more

National Institute of Mental Health (NIMH)NCT04631042

~$10 – $675

Irritability Associated With Autism Spectrum Disorder

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability ass…

Intra-Cellular Therapies, Inc.NCT06690398

Irritability Associated With Autism Spectrum Disorder

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability ass…

Intra-Cellular Therapies, Inc.NCT06706674

Observational

Empowering Caregivers to Promote Child Independence and Persistence With Activities

The proposed study aims to address the unique needs of caregivers and their adolescent children with profound autism. The constant supervision and 24/7 care th…

Profound Autism

University of NebraskaNCT07059364

~$10 – $6,250

Phase 1

Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study

This 12-month study tests whether AdiaVita (umbilical cord blood-derived stem cells and exosomes) plus glutathione improves autism symptoms more than glutathio…

Autism Spectrum DisorderAutismASD+1 more

Documented

$12,000

Adia Med of Winter Park LLCNCT07304440

SchizophreniaAutism-Related Irritability

A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride in Children and Adolescents With Psychiatric Disorders

The purpose of this study is to evaluate the long-term safety and tolerability of Xanomeline and Trospium Chloride for the treatment of psychiatric disorders i…

Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT07424404

Phase 1

An Open-Label Phase I Clinical Trial of Vancomycin Followed by Familial Fecal Microbiota Transplant in Adult Subjects With Autism Spectrum Disorder (ASD)

This is an open-label clinical trial to evaluate the benefits of familial fecal microbiota transplant following a 6-week treatment with Vancomycin in adult sub…

AutismAutism Spectrum Disorder

AnxietyAutism Spectrum Disorder

~$10 – $7,500

ProgenaBiomeNCT04630847

Phase 4

A Randomized Controlled Trial of Buspirone for Anxiety in Autistic Youth

The purpose of the study is to do a preliminary trial to determine if buspirone is effective, safe, and tolerable in autistic youth with anxiety.